BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 21871820)

  • 21. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome.
    Langenbach SY; Zheng L; McWilliams T; Levvey B; Orsida B; Bailey M; Williams TJ; Snell GI
    J Heart Lung Transplant; 2005 Oct; 24(10):1550-6. PubMed ID: 16210129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis.
    Lin FC; Chen YC; Chang SC
    Mayo Clin Proc; 2008 Dec; 83(12):1344-9. PubMed ID: 19046553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients.
    Nord M; Schubert K; Cassel TN; Andersson O; Riise GC
    Transplantation; 2002 Apr; 73(8):1264-9. PubMed ID: 11981419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection.
    Slebos DJ; Postma DS; Koëter GH; Van Der Bij W; Boezen M; Kauffman HF
    J Heart Lung Transplant; 2004 May; 23(5):532-40. PubMed ID: 15135367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome.
    Verleden GM; Vanaudenaerde BM; Dupont LJ; Van Raemdonck DE
    Am J Respir Crit Care Med; 2006 Sep; 174(5):566-70. PubMed ID: 16741151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bronchial hyperresponsiveness and the bronchiolitis obliterans syndrome after lung transplantation.
    Reid DW; Walters EH; Johns DP; Ward C; Burns GP; Liakakos P; Williams TJ; Snell GI
    J Heart Lung Transplant; 2005 Apr; 24(4):489-92. PubMed ID: 15797754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum KL-6 as a novel disease marker in adolescent and adult cystic fibrosis.
    Ohshimo S; Bonella F; Grammann N; Starke K; Cui A; Bauer PC; Teschler H; Kohno N; Guzman J; Costabel U
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):47-53. PubMed ID: 19960788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
    Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
    Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
    J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study.
    Verleden GM; Verleden SE; Vos R; De Vleeschauwer SI; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
    Transpl Int; 2011 Jul; 24(7):651-6. PubMed ID: 21401732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome.
    Brugière O; Thabut G; Mal H; Marceau A; Dauriat G; Marrash-Chahla R; Castier Y; Lesèche G; Colombat M; Fournier M
    Eur Respir J; 2005 May; 25(5):813-9. PubMed ID: 15863637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Airway colonization and gastric aspiration after lung transplantation: do birds of a feather flock together?
    Vos R; Blondeau K; Vanaudenaerde BM; Mertens V; Van Raemdonck DE; Sifrim D; Dupont LJ; Verleden GM
    J Heart Lung Transplant; 2008 Aug; 27(8):843-9. PubMed ID: 18656796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.
    Gottlieb J; Mattner F; Weissbrodt H; Dierich M; Fuehner T; Strueber M; Simon A; Welte T
    Respir Med; 2009 May; 103(5):743-9. PubMed ID: 19117741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer?
    Vos R; Vanaudenaerde BM; Ottevaere A; Verleden SE; De Vleeschauwer SI; Willems-Widyastuti A; Wauters S; Van Raemdonck DE; Nawrot TS; Dupont LJ; Verleden GM
    J Heart Lung Transplant; 2010 Dec; 29(12):1358-68. PubMed ID: 20619683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.
    Lama VN; Murray S; Lonigro RJ; Toews GB; Chang A; Lau C; Flint A; Chan KM; Martinez FJ
    Am J Respir Crit Care Med; 2007 Jun; 175(11):1192-8. PubMed ID: 17347496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
    Jaksch P; Taghavi S; Klepetko W; Salama M
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):273-81. PubMed ID: 24685381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome.
    Borro JM; Bravo C; Solé A; Usetti P; Zurbano F; Lama R; De la Torre M; Román A; Pastor A; Laporta R; Cifrián JM; Santos F
    Transplant Proc; 2007 Sep; 39(7):2416-9. PubMed ID: 17889206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Krebs Von Den Lungen-6 as a Biomarker for Early Detection of Bronchiolitis Obliterans Syndrome in Children Undergoing Allogeneic Stem Cell Transplantation.
    Gassas A; Schechter T; Krueger J; Craig-Barnes H; Sung L; Ali M; Dell S; Egeler RM; Zaidman I; Palaniyar N
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1524-8. PubMed ID: 25963919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1.
    Burton CM; Iversen M; Carlsen J; Mortensen J; Andersen CB; Steinbrüchel D; Scheike T
    J Heart Lung Transplant; 2009 Sep; 28(9):888-93. PubMed ID: 19716040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
    Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.